FDA Inspection 1217382 — Sri Krishna Pharmaceuticals Limited - Unit IV

Sri Krishna Pharmaceuticals Limited - Unit IV — FEI 3005408438

The FDA completed an inspection of Sri Krishna Pharmaceuticals Limited - Unit IV on Aug 4, 2023 in Sangareddy. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Veterinary.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Aug 4, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Sangareddy (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.